Cargando…
Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009
BACKGROUND: The purpose of this study was to investigate the completeness of TNM (Tumor, Node, Metastasis) staging for breast cancer in the Danish Cancer Registry. METHODS: We identified 26,488 patients with a first diagnosis of breast cancer between 2004 and 2009 from the Danish Cancer Registry. We...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429150/ https://www.ncbi.nlm.nih.gov/pubmed/22936852 http://dx.doi.org/10.2147/CLEP.S31574 |
_version_ | 1782241775077818368 |
---|---|
author | Ording, Anne Gulbech Nielsson, Malene Schou Frøslev, Trine Friis, Søren Garne, Jens Peter Søgaard, Mette |
author_facet | Ording, Anne Gulbech Nielsson, Malene Schou Frøslev, Trine Friis, Søren Garne, Jens Peter Søgaard, Mette |
author_sort | Ording, Anne Gulbech |
collection | PubMed |
description | BACKGROUND: The purpose of this study was to investigate the completeness of TNM (Tumor, Node, Metastasis) staging for breast cancer in the Danish Cancer Registry. METHODS: We identified 26,488 patients with a first diagnosis of breast cancer between 2004 and 2009 from the Danish Cancer Registry. We obtained information on comorbidity through the Danish National Patient Registry. We estimated the completeness of TNM registration in the Danish Cancer Registry and stratified the analysis by gender, age, year of cancer diagnosis, and comorbidity. We designed an algorithm categorizing breast cancer into localized, regional, distant, or unknown stage based on TNM codes. RESULTS: The overall completeness of TNM registration was 85.4%. The completeness varied little by gender and study year, but decreased from 91.3% in patients aged 0–39 years to 57.0% in patients aged 80 years or more, and from 87.9% among patients with a low level of comorbidity to 69.7% among patients with a high level of comorbidity. CONCLUSION: The completeness of the TNM registration varied substantially by age and level of comorbidity. Thus, depending on the outcome under study, stage-specific analyses may yield biased results. The completeness of TNM should be considered in study designs using TNM information. |
format | Online Article Text |
id | pubmed-3429150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-34291502012-08-30 Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009 Ording, Anne Gulbech Nielsson, Malene Schou Frøslev, Trine Friis, Søren Garne, Jens Peter Søgaard, Mette Clin Epidemiol Short Report BACKGROUND: The purpose of this study was to investigate the completeness of TNM (Tumor, Node, Metastasis) staging for breast cancer in the Danish Cancer Registry. METHODS: We identified 26,488 patients with a first diagnosis of breast cancer between 2004 and 2009 from the Danish Cancer Registry. We obtained information on comorbidity through the Danish National Patient Registry. We estimated the completeness of TNM registration in the Danish Cancer Registry and stratified the analysis by gender, age, year of cancer diagnosis, and comorbidity. We designed an algorithm categorizing breast cancer into localized, regional, distant, or unknown stage based on TNM codes. RESULTS: The overall completeness of TNM registration was 85.4%. The completeness varied little by gender and study year, but decreased from 91.3% in patients aged 0–39 years to 57.0% in patients aged 80 years or more, and from 87.9% among patients with a low level of comorbidity to 69.7% among patients with a high level of comorbidity. CONCLUSION: The completeness of the TNM registration varied substantially by age and level of comorbidity. Thus, depending on the outcome under study, stage-specific analyses may yield biased results. The completeness of TNM should be considered in study designs using TNM information. Dove Medical Press 2012-08-17 /pmc/articles/PMC3429150/ /pubmed/22936852 http://dx.doi.org/10.2147/CLEP.S31574 Text en © 2012 Ording et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Short Report Ording, Anne Gulbech Nielsson, Malene Schou Frøslev, Trine Friis, Søren Garne, Jens Peter Søgaard, Mette Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009 |
title | Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009 |
title_full | Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009 |
title_fullStr | Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009 |
title_full_unstemmed | Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009 |
title_short | Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009 |
title_sort | completeness of breast cancer staging in the danish cancer registry, 2004–2009 |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429150/ https://www.ncbi.nlm.nih.gov/pubmed/22936852 http://dx.doi.org/10.2147/CLEP.S31574 |
work_keys_str_mv | AT ordingannegulbech completenessofbreastcancerstaginginthedanishcancerregistry20042009 AT nielssonmaleneschou completenessofbreastcancerstaginginthedanishcancerregistry20042009 AT frøslevtrine completenessofbreastcancerstaginginthedanishcancerregistry20042009 AT friissøren completenessofbreastcancerstaginginthedanishcancerregistry20042009 AT garnejenspeter completenessofbreastcancerstaginginthedanishcancerregistry20042009 AT søgaardmette completenessofbreastcancerstaginginthedanishcancerregistry20042009 |